Dr. Pamela K Woodard, M.D
Claim this profileDepartment of Radiology
Studies Coronary Artery Disease
Studies Motor Function
2 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Pamela K Woodard, M.D is currently running
Gadolinium-Based Contrast Media Effects on Motor and Cognitive Functioning
for undefined
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.
Recruiting3 awards Phase 49 criteria
Myocardial Perfusion Imaging
for Coronary Artery Disease
A single center, phase 0/1 clinical imaging study designed to assess the role of \[68Ga\]Galmydar PET/CT imaging in human subjects.
Recruiting1 award Phase < 12 criteria
More about Pamela K Woodard, M.D
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Pamela K Woodard, M.D has experience with
- 13N-ammonia
- Ga-68 Galmydar
- Gadobenate Dimeglumine
- Gadobutrol
- Gadodiamide
- Gadoterate Meglumine
Breakdown of trials Pamela K Woodard, M.D has run
Coronary Artery Disease
Cognitive Functioning
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pamela K Woodard, M.D specialize in?
Pamela K Woodard, M.D focuses on Coronary Artery Disease and Motor Function. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Pamela K Woodard, M.D currently recruiting for clinical trials?
Yes, Pamela K Woodard, M.D is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Pamela K Woodard, M.D has studied deeply?
Yes, Pamela K Woodard, M.D has studied treatments such as 13N-ammonia, Ga-68 Galmydar, Gadobenate dimeglumine.
What is the best way to schedule an appointment with Pamela K Woodard, M.D?
Apply for one of the trials that Pamela K Woodard, M.D is conducting.
What is the office address of Pamela K Woodard, M.D?
The office of Pamela K Woodard, M.D is located at: Department of Radiology, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Department of Radiology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.